CD8A and neoplasm: Although, IL-10 has been broadly characterized as an immune suppressor, at higher concentrations IL-10 and PEGylated IL-10 (pegilodecakin) has shown to have properties that enhance cytotoxicity and proliferative capacity of tumor-specific CD8+ T cells (113–115).